Xerys

Name

Xerys

Legal name

Xerys Invest SAS

Website

https://xerys.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Private Equity & Venture Capital Management

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

• Venture capital management
• Private equity funds
• Biotech investments
• Cleantech investments
• Portfolio management

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Management Fees and Performance Fees (Carried Interest): Xerys Invest generates revenue through management fees charged on assets under management and performance fees (carried interest) on investment returns, typical for a private equity and venture capital fund management structure. The firm raises capital from investors (family offices, institutions, high-net-worth individuals) and deploys it into unlisted portfolio companies.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Xerys Invest SAS is a French AMF-accredited portfolio management company (private equity/venture capital firm) that raises capital from institutional investors, family offices, and high-net-worth individuals and deploys it into unlisted growth-stage SMEs in two target sectors: Healthcare & Life Sciences and Sustainable Development / GreenTech. The firm provides €15M–€90M investment tickets, active strategic and operational support, and continuity of capital from venture stage through to maturity or IPO across a concentrated portfolio of approximately 6 active companies.

Differentiator

Problem solved

Functional benefit

Brands

• PowiDian Energy: Hydrogen stationary energy storage and power generation solutions for industrial and large-scale applications
• PowiDian Mobility

Products and services

• Xerys Investment Funds Private equity and venture capital investment funds (Fonds Xerys) that deploy capital of €15–90M per company into innovative unlisted SMEs in Healthcare & Life Sciences and Sustainable Development sectors. The funds are offered to institutional investors, family offices, and high-net-worth individuals seeking access to unlisted growth-stage companies.
• Portfolio Company Management Long-term strategic, operational, and governance support services provided to portfolio companies from venture capital stage through to maturity. Includes proximity-based partnership with portfolio company management, access to Xerys strategic committee experts, and assistance with strategic decisions and value creation. Provided to founders and management teams of Xerys portfolio companies.
• Strategic Advisory Services Sectoral and strategic advisory provided through Xerys' strategic committee, which is composed of internationally recognized specialists and senior executives (including industry experts and former BCG senior partners). Delivered to portfolio companies and entrepreneurs seeking expert guidance in healthcare and sustainable development sectors.

Quantifiable outcome

• Xerys manages over €200M in assets with 9+ portfolio companies and successful exits (Cryo Pur, Optionizr, Sevenhugs).
• +5 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered supporting and core.

• GRZ Technologies SAsupportingTechnology or Integration · 1 January 2025PowiDian Energy signed a partnership with GRZ Technologies SA at the Hyvolution Paris trade show to expand its range of hydrogen storage solutions for industrial and large-scale applications, combining PowiDian's hydrogen generation systems with GRZ's storage technology.
• Bouygues Energies & ServicessupportingStrategic or Co-development Partner · 1 January 2025Bouygues Energies & Services, a partner in the energy and digital transformation of territories and industries, partnered with PowiDian to advance hydrogen-based stationary energy solutions.
• Khalid Scientific Co. (KSC)supportingChannel Partner/ Reseller/ Distributor · 1 January 2024Khalid Scientific Co. (KSC) serves as Biolog-id's local partner in Qatar, supporting the deployment of Biolog-Transfusion solutions at Hamad Medical Corporation in Doha. KSC is a diversified company with 8 divisions covering medical equipment, laboratory, imaging, cardiology, and healthcare facility operations.
• L.M.I. (Leaders Mobility Innovation)coreStrategic or Co-development Partner · 1 September 2021PowiDian signed a Letter of Intent (LOI) to acquire L.M.I., a specialist in innovative mobility systems with over 30 years of experience in designing and manufacturing utility vehicles, based in Le Mans. This led to the creation of PowiDian Mobility to address the green mobility market.
• PolytradesupportingChannel Partner/ Reseller/ Distributor · 1 June 2021SKYTECH signed a distribution partnership with Polytrade to expand its premium recycled plastic resin sales across Italy as part of its international rollout following the acquisition of the Pozzaglio ed Uniti manufacturing site.
• Hôpital Fondation Adolphe de RothschildsupportingImplementation/ SI/ Consulting Partner · 1 May 2021AlzProtect signed a collaboration agreement with Fondation Adolphe de Rothschild Hospital to open a third clinical site in Paris for the Phase 2a trial of AZP2006 (Ezeprogind) for PSP, under Rothschild Medical Development. The hospital, a leading neurology center, manages a large PSP patient cohort.
• Luxembourg Institute of Health (LIH)supportingStrategic or Co-development Partner · 1 July 2020Advanced BioDesign and the LIH's TIME research group (Tumor Immunotherapy and MicroEnvironment) led by Dr. Bassam Janji established a collaborative program to study the efficacy of Advanced BioDesign's compounds in preclinical models of melanoma and lung cancer, particularly focusing on tumor immunosuppression mechanisms.
• Ballard Power Systems EuropesupportingTechnology or Integration · 1 January 2020PowiDian and Ballard Power Systems Europe entered into a collaboration for hydrogen fuel cell-powered utility vehicles. Ballard is a leading fuel cell manufacturer, and PowiDian integrates their technology into its PowiDian Mobility electric utility vehicles with hydrogen range extension.
• Polymers Energy Recovery Innovation (APR2)supportingStrategic or Co-development Partner · 1 January 2020SKYTECH developed its triboelectric sorting technology in partnership with APR2, a company specializing in collection, dismantling, and recycling of Waste Electrical and Electronic Equipment (WEEE), supported by ADEME.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Ardian: Global private investment house headquartered in Paris with €160B+ AUM across PE, infrastructure, and growth. A broad incumbent that competes for the same European mid-market growth deals as Xerys, though at a much larger scale.
• Bpifrance: French state-backed investment bank and fund-of-funds that co-invests in many of the same growth-stage French SMEs as Xerys (including funding for SKYTECH, AlzProtect). A larger, more diversified player in the same market but with a public-policy mandate rather than pure commercial PE.
• Eurazeo: One of Europe's largest listed private equity firms with broad Healthcare, Tech, and Sustainable Development exposure. Operates as a broad incumbent in the same French and European mid-market growth segment as Xerys but at significantly larger scale.
• Tikehau Capital: Paris-listed alternative asset manager with private equity, private debt, and real assets strategies. Overlaps with Xerys in French mid-market growth equity and has a sustainability/energy transition focus that intersects with the PowiDian/SKYTECH portfolio themes.

Emerging players

• Capagro: French independent PE firm specializing in agtech, foodtech, and the bioeconomy. Emerging player with thematic overlap to Xerys's Sustainable Development portfolio (SKYTECH recycled plastics, PowiDian energy), though with a narrower food-and-agriculture focus.
• Cathay Innovation: Paris-based global growth equity firm with €2.5B+ AUM, focused on technology and digital transformation across Europe, US, and Asia. Comparable as a sector-thematic growth investor with similar ticket sizes, though concentrated in software/AI rather than healthcare/cleantech.
• Capital Croissance: French independent PE firm providing €10-50M tickets to French SMEs in healthcare, tech, and sustainable development. Highly comparable to Xerys in scale, ticket size, and sector focus, but with a broader geographic and sector mandate.

Direct peers

• Seventure Partners: French venture capital firm with healthcare, digital, and sustainability-focused strategies. Comparable as a French multi-strategy growth investor targeting similar Healthcare and Sustainable Development themes.
• Sofinnova Partners: One of Europe's largest life-sciences specialist venture capital firms, with deep French roots and a multi-stage healthcare investment strategy. Directly comparable on the biotech/medtech side of Xerys's healthcare portfolio (Advanced BioDesign, AlzProtect).
• Andera Partners: French multi-strategy private investment firm (formerly Idinvest Partners) with active/growth equity, private debt, and healthcare-focused strategies. Directly comparable to Xerys as a French PE firm with healthcare and growth-company focus, and similar ticket sizes for growth-stage investments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xxerys.com/en
• LinkedInlinkedin.com/company/1481827

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments18 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xerys